Nasdaq: ATTO
Attovia Therapeutics insiders
The officers, directors and 10% owners of Attovia Therapeutics, Inc. who hold the most stock, valued at the live ATTO price.
$15.58
ATTO today +$50K (+0.32%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 5
- Their ATTO stock
- $265M
- Market value
- $712M
- Held by ranked insiders
- 37.3%
Insiders by value of ATTO holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Fhmls Xi, L.P. | 10% owner | 6,154,213 | $95.9M | 13.5% | Corporate |
| 2 | venBio Global Strategic Fund IV, L.P. | 10% owner | 4,181,367 | $65.1M | 9.15% | Corporate |
| 3 | Alamar HoldCo, LLC | 10% owner | 3,229,278 | $50.3M | 7.06% | Corporate |
| 4 | Colin Walsh | Director | 3,020,632 | $47.1M | 6.61% | 2659th |
| 5 | Tao Fu | President and CEO | 449,371 | $7.0M | 0.98% | 11397th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Attovia Therapeutics; see each profile for the filing.